1. Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. Issue 30 (20th October 2021) Authors: Roddie, Claire; Dias, Juliana; O'Reilly, Maeve A.; Abbasian, Mahnaz; Cadinanos-Garai, Amaia; Vispute, Ketki; Bosshard-Carter, Leticia; Mitsikakou, Marina; Mehra, Vedika; Roddy, Harriet; Hartley, John A.; Spanswick, Victoria; Lowe, Helen; Popova, Bilyana; Clifton-Hadley, Laura; Wheeler, Graham; Ol... Journal: Journal of clinical oncology Issue: Volume 39:Issue 30(2021) Page Start: 3352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗